ARCHETYPE Classification of age related macular degeneration (openEHR-EHR-CLUSTER.classification_amd.v0)

ARCHETYPE IDopenEHR-EHR-CLUSTER.classification_amd.v0
ConceptClassification of age related macular degeneration
DescriptionClassifies the condition and argues the diagnostic decision for age-related macular degeneration.
UseProvide details about grading or staging of age-related macular degeneration. It is useful to specify the overall diagnoses provided using the "problem/diagnosis" archetype.
PurposeRegister the stage of age-related macular degeneration for a patient at a given time.
References- American Academy of Ophthalmology RVP. Age-Related Macular Degeneration. Preferred Practice Pattern® Guidelines. San Francisco, CA: American Academy of Ophthalmology; 2015.
Copyright© openEHR Foundation
AuthorsAuthor name: Aitor Eguzkitza
Organisation: Universidad Pública de Navarra - Complejo Hospitalario de Navarra
Email: aitor.eguzkiza@unavarra.es
Date originally authored: 2015-06-23
Other Details LanguageAuthor name: Aitor Eguzkitza
Organisation: Universidad Pública de Navarra - Complejo Hospitalario de Navarra
Email: aitor.eguzkiza@unavarra.es
Date originally authored: 2015-06-23
Other Details (Language Independent)
  • Licence: This work is licensed under the Creative Commons Attribution-ShareAlike 3.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by-sa/3.0/.
  • Custodian Organisation: openEHR Foundation
  • References: - American Academy of Ophthalmology RVP. Age-Related Macular Degeneration. Preferred Practice Pattern® Guidelines. San Francisco, CA: American Academy of Ophthalmology; 2015.
  • Original Namespace: org.openehr
  • Original Publisher: openEHR Foundation
  • Custodian Namespace: org.openehr
  • MD5-CAM-1.0.1: C1FDECFA2EFBC41ECE3FCA974433EEE7
  • Build Uid: 7ac0f5a4-2829-4d46-bd49-c7923135833c
  • Revision: 0.0.1-alpha
Keywords
Lifecyclein_development
UIDfe1524ce-ea02-464a-9156-1326cd7ba0f1
Language useden
Citeable Identifier1013.1.2117
Revision Number0.0.1-alpha
items
AMD classificationAMD classification: Clinical grade determined for age-related macular degeneration.
  • No AMD [No or a few (<5) small drusen (<63 micrometres in diameter).]
  • Early AMD [Many small drusen or a few intermediate-sized (63-124 micrometres in diameter) drusen, or macular pigmentary changes.]
  • Intermediate AMD [Extensive intermediate drusen or at least one large (≥125 micrometres) drusen, or geographic atrophy not involving the foveal centre.]
  • Dry advanced AMD atrophic [Geographic atrophy involving the foveal centre.]
  • Exudative or wet AMD [Choroidal neovascularisation or evidence for neovascular maculopathy (subretinal haemorrhage, serous retinal or retinal pigment epithelium detachments, lipid exudates, or fibrovascular scar).]
    [SNOMED-CT::414173003 | Exudative age-related macular degeneration]
  • Ungradable [Patient ungradable due to the low quality of acquisitions or uncertainty of the evaluator.]
    [SNOMED-CT::408313004 | O/E - non-referable retinopathy]
Diagnostic criteriaDiagnostic criteria: Clinical findings supporting the diagnose or grading.
  • Small drusen [Drusen < 63 µm in diameter.]
  • Intermediate drusen [Drusen 63-124 µm in diameter.]
  • Numerous intermediate drusen [More than x drusen 63-124 µm in diameter.]
  • Large drusen [Drusen ≥125 µm in diameter.]
  • Geographic atrophy [A sharply demarcated, usually round or oval, area of atrophy of the RPE not involving the center of the fovea.]
  • Geographic atrophy involving foveal center [Geographic atrophy of the RPE involving the foveal center.]
  • Choroidal neovascularization (CNV) [Pathologic angiogenesis originating from the choroidal vasculature that extends through a defect in Bruch's membrane.]
  • Serous or hemorragic detachment [Serous or hemorragic detachment of the neourosensory retina or RPE.]
  • Retinal hard exudates [Hard exudates resulting from chronic intravascular leakage.]
  • Fibrovascular proliferation [Subretinal and sub-RPE fibrovascular proliferation.]
  • Disciform scar (subretinal fibrosis) [Subretinal fibrovascular tissue that usually becomes more fibrous within a few years and that is often the end result of CNV.]
Clinical findingsClinical findings: Overall findings on the patient considered in the diagnostic classification.
Constraint:
Findings in posterior pole of eye
[List of clinical findings identifiable in posterior pole of eye.]
CommentsComments: Additional comments that clarify the diagnostic decision made.
Other contributors
Translators